c-Src Binds to the Cancer Drug Ruxolitinib with an Active Conformation
Figure 1
Structure of c-Src in complex with Ruxolitinib.
(A) Overall structure of c-Src/Ruxolitinib complex. (B) The pyrrolopyrimidine rings form two hydrogen bonds with the main chain atoms of Met341. (C) Ruxolitinib forms a water-mediated interaction with Src gatekeeper residue Thr338.